USSTOCK.TODAY
Market Closed
Log in Sign up

Barclays downgrades Fresenius Medical Care and lowers price target

Investing.com · ·by G4L

BCS Barclays plc ADR
$23.15 +0.22%
View chart & analysis →
FMS FMS -2.29%
  1. 1Barclays downgraded the investment rating of Fresenius Medical Care from 'equal weight' to 'underweight'.
  2. 2Barclays lowered the price target for Fresenius Medical Care from 44.50 euros to 35 euros.
  3. 3Barclays projected a 3% average annual decline in Fresenius Medical Care's adjusted EBIT between 2025 and 2028.

So what's the key point?

Barclays has lowered its outlook for Fresenius Medical Care's stock price. The bank expects the company's profits to decrease by 3% each year moving forward.

Source Investing.com · View original ↗

Related 3-line summaries

Barclays assigns 'equal weight' rating to THG with 42p price target Investing.com · 8h agoBarclays Launches Samsung Galaxy Card and Strengthens Partnership Banking Dive · 4d agoLack of AI financial returns outside tech sector and corporate cost burdens Fortune · 5d ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news